Legis Daily

To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.

USA115th CongressHR-1203| House 
| Updated: 2/24/2017
F. James Sensenbrenner

F. James Sensenbrenner

Republican Representative

Wisconsin

Cosponsors (10)
Mike Johnson (Republican)Martha Roby (Republican)Jim Banks (Republican)Andy Biggs (Republican)Jeff Duncan (Republican)Jodey C. Arrington (Republican)Steve Russell (Republican)Ted S. Yoho (Republican)Tom Emmer (Republican)Sean P. Duffy (Republican)

Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act or the Safe RESEARCH Act This bill amends the Public Health Service Act to prohibit the use of tissue from an induced abortion in research conducted or supported by the National Institutes of Health (NIH). Research with human fetal tissue or alternatives to human fetal tissue (e.g., stem cells) conducted or supported by the NIH must meet requirements currently applied only to research on the transplantation of human fetal tissue for therapeutic purposes, including requirements for the informed consent of the donor and researcher. Research conducted or supported by the NIH may use human fetal tissue only if the tissue was obtained in accordance with state law regulating anatomical gifts. Currently, executive branch officials may not prohibit the NIH from conducting or supporting research on the transplantation of human fetal tissue for therapeutic purposes. The bill repeals that limitation on executive branch officials. The bill repeals a requirement that the NIH fund certain proposals for research on the transplantation of human fetal tissue for therapeutic purposes.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 17, 2017
Introduced in House
Feb 17, 2017
Referred to the House Committee on Energy and Commerce.
Feb 24, 2017
Referred to the Subcommittee on Health.
  • February 17, 2017
    Introduced in House


  • February 17, 2017
    Referred to the House Committee on Energy and Commerce.


  • February 24, 2017
    Referred to the Subcommittee on Health.

Health

AbortionAdministrative law and regulatory proceduresCell biology and embryologyDepartment of Health and Human ServicesMedical researchOrgan and tissue donation and transplantationResearch administration and funding

To amend the Public Health Service Act to prohibit research with human fetal tissue obtained pursuant to an abortion, and for other purposes.

USA115th CongressHR-1203| House 
| Updated: 2/24/2017
Safe Responsible Ethical Scientific Endeavors Assuring Research for Compassionate Healthcare Act or the Safe RESEARCH Act This bill amends the Public Health Service Act to prohibit the use of tissue from an induced abortion in research conducted or supported by the National Institutes of Health (NIH). Research with human fetal tissue or alternatives to human fetal tissue (e.g., stem cells) conducted or supported by the NIH must meet requirements currently applied only to research on the transplantation of human fetal tissue for therapeutic purposes, including requirements for the informed consent of the donor and researcher. Research conducted or supported by the NIH may use human fetal tissue only if the tissue was obtained in accordance with state law regulating anatomical gifts. Currently, executive branch officials may not prohibit the NIH from conducting or supporting research on the transplantation of human fetal tissue for therapeutic purposes. The bill repeals that limitation on executive branch officials. The bill repeals a requirement that the NIH fund certain proposals for research on the transplantation of human fetal tissue for therapeutic purposes.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 17, 2017
Introduced in House
Feb 17, 2017
Referred to the House Committee on Energy and Commerce.
Feb 24, 2017
Referred to the Subcommittee on Health.
  • February 17, 2017
    Introduced in House


  • February 17, 2017
    Referred to the House Committee on Energy and Commerce.


  • February 24, 2017
    Referred to the Subcommittee on Health.
F. James Sensenbrenner

F. James Sensenbrenner

Republican Representative

Wisconsin

Cosponsors (10)
Mike Johnson (Republican)Martha Roby (Republican)Jim Banks (Republican)Andy Biggs (Republican)Jeff Duncan (Republican)Jodey C. Arrington (Republican)Steve Russell (Republican)Ted S. Yoho (Republican)Tom Emmer (Republican)Sean P. Duffy (Republican)

Health Subcommittee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
AbortionAdministrative law and regulatory proceduresCell biology and embryologyDepartment of Health and Human ServicesMedical researchOrgan and tissue donation and transplantationResearch administration and funding